Sign in to edit your profile (add interests, overview, photo, etc.)
    LBNL Profiles Metrics
    22833 Publications
    3073 Total Profiles
    24 Edited Profiles

    Mihalik, Stephanie

    TitleBiologist Project Sci/Engr
    SchoolLawrence Berkeley National Lab
    DepartmentLife Sciences
    Address1 Cyclotron Road
    Berkeley CA 94720
    Phone510/486-6526

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can sign in to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Zacherl JR, Tourkova I, St Croix CM, Robinson LJ, Peck Palmer OM, Mihalik SJ, Blair HC. Elaidate, an 18-Carbon Trans-monoenoic Fatty Acid, but Not Physiological Fatty Acids Increases Intracellular Zn(2+) in Human Macrophages. J Cell Biochem. 2015 Apr; 116(4):524-32.
        View in: PubMed
      2. Zacherl JR, Mihalik SJ, Chace DH, Christensen TC, Robinson LJ, Blair HC. Elaidate, an 18-Carbon trans-Monoenoic Fatty Acid, Inhibits ß-Oxidation in Human Peripheral Blood Macrophages. J Cell Biochem. 2014 Jan; 115(1):62-70.
        View in: PubMed
      3. Michaliszyn SF, Sjaarda LA, Mihalik SJ, Lee S, Bacha F, Chace DH, De Jesus VR, Vockley J, Arslanian SA. Metabolomic profiling of amino acids and ß-cell function relative to insulin sensitivity in youth. J Clin Endocrinol Metab. 2012 Nov; 97(11):E2119-24.
        View in: PubMed
      4. Mihalik SJ, Michaliszyn SF, de las Heras J, Bacha F, Lee S, Chace DH, DeJesus VR, Vockley J, Arslanian SA. Metabolomic profiling of fatty acid and amino acid metabolism in youth with obesity and type 2 diabetes: evidence for enhanced mitochondrial oxidation. Diabetes Care. 2012 Mar; 35(3):605-11.
        View in: PubMed
      5. Wang Y, Mohsen AW, Mihalik SJ, Goetzman ES, Vockley J. Evidence for physical association of mitochondrial fatty acid oxidation and oxidative phosphorylation complexes. J Biol Chem. 2010 Sep 24; 285(39):29834-41.
        View in: PubMed
      6. Mihalik SJ, Goodpaster BH, Kelley DE, Chace DH, Vockley J, Toledo FG, DeLany JP. Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. Obesity (Silver Spring). 2010 Sep; 18(9):1695-700.
        View in: PubMed
      7. Heinzer AK, Watkins PA, Lu JF, Kemp S, Moser AB, Li YY, Mihalik S, Powers JM, Smith KD. A very long-chain acyl-CoA synthetase-deficient mouse and its relevance to X-linked adrenoleukodystrophy. Hum Mol Genet. 2003 May 15; 12(10):1145-54.
        View in: PubMed
      8. Mihalik SJ, Steinberg SJ, Pei Z, Park J, Kim DG, Heinzer AK, Dacremont G, Wanders RJ, Cuebas DA, Smith KD, Watkins PA. Participation of two members of the very long-chain acyl-CoA synthetase family in bile acid synthesis and recycling. J Biol Chem. 2002 Jul 5; 277(27):24771-9.
        View in: PubMed
      9. Steinberg SJ, Mihalik SJ, Kim DG, Cuebas DA, Watkins PA. The human liver-specific homolog of very long-chain acyl-CoA synthetase is cholate:CoA ligase. J Biol Chem. 2000 May 26; 275(21):15605-8.
        View in: PubMed
      10. Dodt G, Kim DG, Reimann SA, Reuber BE, McCabe K, Gould SJ, Mihalik SJ. L-Pipecolic acid oxidase, a human enzyme essential for the degradation of L-pipecolic acid, is most similar to the monomeric sarcosine oxidases. Biochem J. 2000 Feb 1; 345 Pt 3:487-94.
        View in: PubMed
      11. Dodt G, Kim D, Reimann S, McCabe K, Gould SJ, Mihalik SJ. The human L-pipecolic acid oxidase is similar to bacterial monomeric sarcosine oxidases rather than D-amino acid oxidases. Cell Biochem Biophys. 2000; 32 Spring:313-6.
        View in: PubMed
      12. Steinberg SJ, Wang SJ, Kim DG, Mihalik SJ, Watkins PA. Human very-long-chain acyl-CoA synthetase: cloning, topography, and relevance to branched-chain fatty acid metabolism. Biochem Biophys Res Commun. 1999 Apr 13; 257(2):615-21.
        View in: PubMed
      13. Jansen GA, Mihalik SJ, Watkins PA, Jakobs C, Moser HW, Wanders RJ. Characterization of phytanoyl-Coenzyme A hydroxylase in human liver and activity measurements in patients with peroxisomal disorders. Clin Chim Acta. 1998 Mar 23; 271(2):203-11.
        View in: PubMed
      14. Mihalik SJ, Morrell JC, Kim D, Sacksteder KA, Watkins PA, Gould SJ. Identification of PAHX, a Refsum disease gene. Nat Genet. 1997 Oct; 17(2):185-9.
        View in: PubMed
      15. Jansen GA, Wanders RJ, Watkins PA, Mihalik SJ. Phytanoyl-coenzyme A hydroxylase deficiency -- the enzyme defect in Refsum's disease. N Engl J Med. 1997 Jul 10; 337(2):133-4.
        View in: PubMed
      16. Jansen GA, Mihalik SJ, Watkins PA, Moser HW, Jakobs C, Heijmans HS, Wanders RJ. Phytanoyl-CoA hydroxylase is not only deficient in classical Refsum disease but also in rhizomelic chondrodysplasia punctata. J Inherit Metab Dis. 1997 Jul; 20(3):444-6.
        View in: PubMed
      17. Jansen GA, Mihalik SJ, Watkins PA, Moser HW, Jakobs C, Denis S, Wanders RJ. Phytanoyl-CoA hydroxylase is present in human liver, located in peroxisomes, and deficient in Zellweger syndrome: direct, unequivocal evidence for the new, revised pathway of phytanic acid alpha-oxidation in humans. Biochem Biophys Res Commun. 1996 Dec 4; 229(1):205-10.
        View in: PubMed
      18. Watkins PA, Howard AE, Gould SJ, Avigan J, Mihalik SJ. Phytanic acid activation in rat liver peroxisomes is catalyzed by long-chain acyl-CoA synthetase. J Lipid Res. 1996 Nov; 37(11):2288-95.
        View in: PubMed
      19. Kalish JE, Keller GA, Morrell JC, Mihalik SJ, Smith B, Cregg JM, Gould SJ. Characterization of a novel component of the peroxisomal protein import apparatus using fluorescent peroxisomal proteins. EMBO J. 1996 Jul 1; 15(13):3275-85.
        View in: PubMed
      20. Mihalik SJ, Rainville AM, Watkins PA. Phytanic acid alpha-oxidation in rat liver peroxisomes. Production of alpha-hydroxyphytanoyl-CoA and formate is enhanced by dioxygenase cofactors. Eur J Biochem. 1995 Sep 1; 232(2):545-51.
        View in: PubMed
      21. Watkins PA, Howard AE, Mihalik SJ. Phytanic acid must be activated to phytanoyl-CoA prior to its alpha-oxidation in rat liver peroxisomes. Biochim Biophys Acta. 1994 Oct 6; 1214(3):288-94.
        View in: PubMed
      22. Mihalik SJ, Soliman TM, Day RF, Watkins PA. Involvement of both peroxisomes and mitochondria in the alpha-oxidation of phytanic acid. Prog Clin Biol Res. 1992; 375:239-44.
        View in: PubMed
      23. Mihalik SJ, McGuinness M, Watkins PA. Purification and characterization of peroxisomal L-pipecolic acid oxidase from monkey liver. J Biol Chem. 1991 Mar 15; 266(8):4822-30.
        View in: PubMed
      24. Gärtner J, Chen WW, Kelley RI, Mihalik SJ, Moser HW. The 22-kD peroxisomal integral membrane protein in Zellweger syndrome--presence, abundance, and association with a peroxisomal thiolase precursor protein. Pediatr Res. 1991 Feb; 29(2):141-6.
        View in: PubMed
      25. Watkins PA, Mihalik SJ. Mitochondrial oxidation of phytanic acid in human and monkey liver: implication that Refsum's disease is not a peroxisomal disorder. Biochem Biophys Res Commun. 1990 Mar 16; 167(2):580-6.
        View in: PubMed
      26. Mihalik SJ, Moser HW, Watkins PA, Danks DM, Poulos A, Rhead WJ. Peroxisomal L-pipecolic acid oxidation is deficient in liver from Zellweger syndrome patients. Pediatr Res. 1989 May; 25(5):548-52.
        View in: PubMed
      27. Mihalik SJ, Rhead WJ. L-pipecolic acid oxidation in the rabbit and cynomolgus monkey. Evidence for differing organellar locations and cofactor requirements in each species. J Biol Chem. 1989 Feb 15; 264(5):2509-17.
        View in: PubMed
      28. Moser HW, Mihalik SJ, Watkins PA. Adrenoleukodystrophy and other peroxisomal disorders that affect the nervous system, including new observations on L-pipecolic acid oxidase in primates. Brain Dev. 1989; 11(2):80-90.
        View in: PubMed
      Back to TOP